Overall Technical outlook

Price Summary

GlaxoSmithKline Pharmaceuticals Limited's stock began trading at 2400.2 on 2026-02-02, soared to 2426.6, dipped to 2342.1, and finished the day 0.29% up at 2407.2, with 75479 shares exchanged.
In the past year, the highest stock price was 3466.2, and the lowest was 1960.4.
The anticipated price is forecasted to be between 2500.0 and 3500.0, with an average price expectation of 2943.25, based on input from 4 analysts.

Technicals

Support and Resistance: With the current price at 2407.2, support is found at 2384.2 and resistance at 2509.0. These levels indicate where buyers might step in at 2384.2, while sellers could limit gains at 2509.0, defining a trading boundary for GlaxoSmithKline Pharmaceuticals Limited.
GLAXO supportResistance 2fc51c
Support/Resistance for GLAXO


Aroon: The AROON is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for GLAXO, with no strong trend emerging.
GLAXO aroon 2fc51c
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
GLAXO bbands 2fc51c
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR for GLAXO continues to signal a bullish outlook, establishing a crucial support level that may help sustain the current upward momentum. This level of support suggests that the market is likely to continue trending higher, providing a foundation for ongoing bullish movement.
GLAXO psar 2fc51c
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The STOCHASTIC is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
GLAXO stoch 2fc51c
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the slopes of the faster averages raise the possibility of a reversal for GLAXO. The weakening momentum in these shorter-term averages hints that the upward trend might be losing strength, suggesting that caution may be warranted.
GLAXO trippleSMA 2fc51c
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.